Plakous Therapeutics
PrivateLast Round
Grant
Dec 8, 2025
Total Funding Raised
$5.49M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Plakous Therapeutics is a biotechnology company that develops regenerative biotherapeutics derived from human placental extract to treat inflammation-driven diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Plakous Therapeutics Comparables
Compare Plakous Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Noveome Biotherapeutics | 82% | |
| Siolta Therapeutics | 81% | |
| Infant Bacterial Therapeutics | 77% | |
Plakous Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 8, 2025 | ||||
| Series A | Oct 24, 2025 | ||||
| Grant | Oct 24, 2025 | ||||
| Grant | Jun 1, 2022 | ||||
| Debt | Jun 1, 2022 | ||||
Grant | Jul 8, 2020 |
Plakous Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| North Carolina Biotechnology Center | Debt |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2026
Monthly visitors increased 170% MoM.
- Oct 24, 2025
$3M grant from Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Plakous Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Plakous Therapeutics's valuation, stock price, and market status.